Correction to: British Journal of Cancer (2008) 98, 1614–1618. doi:10.1038/sj.bjc.6604366
In the original submission and subsequent publication of the above paper in the British Journal of Cancer last year, the authors failed to acknowledge the support of the ‘NIHR Biomedical Research Centre, Oxford’ in carrying out their study.
They are now grateful for the chance to correct this omission.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6604366
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Khan, O., Ranson, M., Michael, M. et al. Erratum: A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. Br J Cancer 101, 550 (2009). https://doi.org/10.1038/sj.bjc.6605234
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605234
